3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
23
Breast Neoplasms
14
Neoplasms
7
Carcinoma, Ovarian Epithelial
6
Testicular Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myeloid, Chronic-Phase
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Fatigue
5
Burkitt Lymphoma
5
Blast Crisis
5
Urinary Bladder Neoplasms
4
Primary Myelofibrosis
4
Neuroblastoma
4
Multiple Myeloma
4
Leukemia, Myeloid, Acute
4
Leukemia, Hairy Cell
4
Depression
4
Pdgfra-Associated Chronic Eosinophilic Leukemia
3
Myeloproliferative Disorders
3
Lymphoma, T-Cell, Cutaneous
3
Lung Neoplasms
3
Interventions
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Arteriovenous Malformations
×
Therapeutics
×
Genitourinary
×
Clear all
NCT04272216
2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
99 enrolled
15 charts